Fontex Dreifitafla 20 mg 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

fontex dreifitafla 20 mg

eli lilly danmark a/s - fluoxetinum hýdróklóríð - dreifitafla - 20 mg

Nanogam Innrennslislyf, lausn 50 mg/ml 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

nanogam innrennslislyf, lausn 50 mg/ml

prothya biosolutions netherlands b.v. - immunoglobulinum humanum inn - innrennslislyf, lausn - 50 mg/ml

Prasugrel Krka Filmuhúðuð tafla 5 mg 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

prasugrel krka filmuhúðuð tafla 5 mg

krka, d.d., novo mesto - prasugrelum inn - filmuhúðuð tafla - 5 mg

Spiron (Spironolactone orion) Tafla 100 mg 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

spiron (spironolactone orion) tafla 100 mg

orion corporation - spironolactonum inn - tafla - 100 mg

Spiron (Spironolactone orion) Tafla 25 mg 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

spiron (spironolactone orion) tafla 25 mg

orion corporation - spironolactonum inn - tafla - 25 mg

Spiron (Spironolactone orion) Tafla 50 mg 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

spiron (spironolactone orion) tafla 50 mg

orion corporation - spironolactonum inn - tafla - 50 mg

Tamsulosin Viatris (Tamsulosin Mylan 0,4 mg hart hylki með breyttan losunarhraða) Hart hylki með breyttan losunarhraða 0,4 mg 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

tamsulosin viatris (tamsulosin mylan 0,4 mg hart hylki með breyttan losunarhraða) hart hylki með breyttan losunarhraða 0,4 mg

viatris limited - tamsulosinum hýdróklóríð - hart hylki með breyttan losunarhraða - 0,4 mg

TISSEEL Lausnir fyrir vefjalím 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

tisseel lausnir fyrir vefjalím

baxter medical ab - human fibrinogen; human factor xiii; bovine aprotinin; human thrombin; calcii chloridum; thrombin; protein - lausnir fyrir vefjalím

Zitromax Stofn fyrir innrennslisþykkni, lausn 500 mg 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

zitromax stofn fyrir innrennslisþykkni, lausn 500 mg

pfizer aps - azithromycinum díhýdrat - stofn fyrir innrennslisþykkni, lausn - 500 mg

Qaialdo 유럽 연합 - 아이슬란드어 - EMA (European Medicines Agency)

qaialdo

nova laboratories ireland limited - spironolactone - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 5.